Minnesota 2025-2026 Regular Session

Minnesota Senate Bill SF3271

Introduced
4/3/25  

Caption

Independent audits of 340B entity reporting by nonprofit public interest organizations authorization; revenue from prescription drugs obtained under the 340B program to be used for charity care; enforcement by the attorney general authorization

Summary

SF3271 would change Minnesota law governing 340B covered entities and their reporting obligations. The bill authorizes qualified nonprofit public interest organizations to conduct independent audits of 340B covered entities to determine compliance with existing reporting requirements and the new charity-care requirement. Covered entities would be required to cooperate with those audits and provide requested data and documents, while the auditing organizations would be required to keep the information confidential and may report findings and recommendations to legislative health and human services leaders. The bill also creates a new requirement that 340B covered entities spend at least 25 percent of their annual 340B net revenue on charity care. It defines charity care by reference to existing law and specifies that medical debt write-offs and community service do not count toward the required expenditure. In addition, the bill authorizes enforcement of the new charity-care provision by the attorney general under Minnesota’s consumer-protection/enforcement statute, alongside enforcement by the commissioner.

Impact

The bill would amend Minnesota Statutes section 62J.461 by adding definitions and a new subdivision authorizing independent audits of 340B reporting, and it would add a new section in chapter 144 imposing a mandatory charity-care spending requirement tied to 340B net revenue. Its practical effect would be to increase oversight of hospitals and other 340B covered entities, require disclosure of information to outside nonprofit auditors, and create a new financial obligation directing a portion of 340B-related revenue to charity care. It would also expand enforcement authority by allowing the attorney general to pursue violations.

Sentiment

The available record shows the bill was introduced and referred to the Senate Health and Human Services Committee, but there are no committee transcripts or recorded votes provided. Based on the bill’s structure, the measure appears aimed at increasing transparency and ensuring that 340B savings benefit patients through charity care, suggesting a consumer- and accountability-oriented policy approach. Because no discussion or vote history is included, broader legislative sentiment cannot be determined from the provided materials.

Contention

The main points of contention likely concern the bill’s new audit authority and the mandatory diversion of 25 percent of 340B net revenue to charity care. Covered entities may object to outside nonprofit organizations gaining access to potentially sensitive financial and operational data, even with confidentiality protections, and may also resist the scope of the required disclosures. Hospitals and other 340B participants may also dispute the revenue-use mandate, especially the exclusion of medical debt write-offs and community service from counting toward charity-care obligations. Supporters would likely emphasize transparency, accountability, and ensuring that 340B benefits reach low-income patients.

Companion Bills

No companion bills found.

Previously Filed As

MN HB4327

AUDITOR GENERAL-340B AUDIT

MN HB2081

Creates provisions relating to reporting requirements for entities that participate in the 340B drug pricing program

MN H1527

Prohibitions Against Discriminatory Practices Relating to 340B Entities and 340B Drugs

MN HB1527

Prohibitions Against Discriminatory Practices Relating to 340B Entities and 340B Drugs:

MN HB2965

covered entities; 340B drugs; distribution

MN H1281

Prohibitions Against Discriminatory Practices relating to 340B Entities and 340B Drugs

MN SB1213

Enacts requirements for certain reporting regarding the federal 340B drug program

MN SB1178

Enacts requirements for certain reporting regarding the federal 340B drug program

MN S1638

Prohibitions Against Discriminatory Practices Relating to 340B Entities and 340B Drugs

MN SF3769

340B prescription drugs delivery restrictions prohibition

Similar Bills

No similar bills found.